Your shopping cart is currently empty

Zharp1-211 is a selective and potent RIPK3 inhibitor that significantly reduces the expression of JAK/ stat1-mediated chemokines and MHC class II molecules in IECs, restores intestinal homeostasis, and inhibits graft-versus-host disease (GVHD) for gastrointestinal inflammation.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $79 | In Stock | In Stock | |
| 5 mg | $193 | In Stock | In Stock | |
| 10 mg | $297 | In Stock | In Stock | |
| 25 mg | $592 | In Stock | In Stock | |
| 50 mg | $919 | In Stock | In Stock | |
| 100 mg | $1,380 | - | In Stock | |
| 200 mg | $1,860 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $213 | In Stock | In Stock |
| Description | Zharp1-211 is a selective and potent RIPK3 inhibitor that significantly reduces the expression of JAK/ stat1-mediated chemokines and MHC class II molecules in IECs, restores intestinal homeostasis, and inhibits graft-versus-host disease (GVHD) for gastrointestinal inflammation. |
| In vitro | Zharp1-211 was highly potent for blocking TNF-induced necroptosis in human colon cancer HT-29 cells and mouse fibroblast L929 cells, and reduced IFN-γ–induced STAT1 activation in mouse intestinal crypt cells by affecting the JAK1/STAT1 pathway. [1] |
| In vivo | Oral administration of Zharp1-211 (10 mg/kg) starting on day 7 after T cell transplantation significantly reduced GVHD severity and improved survival in multiple mouse models. Zharp-211 alleviated inflammation in the colon, small intestine, liver, and skin, preserved intestinal stem and Paneth cells, suppressed chemokine expression, reduced alloreactive T and CXCR3⁺ T cells, and inhibited STAT1 activation and necroptosis/apoptosis in the gut. [2] |
| Synonyms | Zharp1211 |
| Molecular Weight | 447.49 |
| Formula | C24H25N5O4 |
| Cas No. | 2258671-41-7 |
| Smiles | O=C(OC1CCOCC1)N2C=3C=C(C=NC3CC2)C=4C=CC5=NC(=CN5C4)NC(=O)C6CC6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
| Solubility Information | DMSO: 8 mg/mL (17.88 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.